Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders
constipation
1 other identifier
interventional
50
1 country
1
Brief Summary
Emptying disorders are of the most common causes of constipation. An adjustable toilet seat was designed by " Shva-Nach" Ltd company, and is designed to facilitate the angle sitting position. Its efficacy will be evaluated in the current study, on 50 volunteers who suffer from constipation and meet the Rome 3 criteria for constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2014
CompletedFirst Posted
Study publicly available on registry
February 20, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedFebruary 20, 2014
February 1, 2014
1.8 years
February 18, 2014
February 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in bowel movement frequency
2 months
Secondary Outcomes (1)
Improvement in quality of life
2 months
Study Arms (2)
Experimental toilet seat
EXPERIMENTALExperimental toilet seat for 1 month
Standard toilet seat
SHAM COMPARATORStandard toilet seat for 1 month
Interventions
Eligibility Criteria
You may qualify if:
- Patients suffering from constipation and meet the criteria of Rome 3. No sub - distribution by emptying disorders or decreased stool frequency
- Age group 18-80 years
- Study population may include patients suffering from metabolic diseases such as diabetes mellitus, hypothyroidism and hypercalcemia.
- Patients who understand the goals of the research and collaborate
You may not qualify if:
- Patients who do not understand the goals of the research and / or unable to cooperate.
- women with known pregnancy - second trimester and up
- Patients with obesity - BMI\> 35 and / or weight over 120 kg
- Neurological diseases - dementia, Parkinson's disease, CVA, multiple sclerosis, muscular dystrophy, spinal cord injury
- Disabled patients on wheelchairs.
- Patients with active anal fissure / fistula, active inflammation of the colon, patients after resection of the colon.
- Minors and no judgment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 6423966, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2014
First Posted
February 20, 2014
Study Start
March 1, 2014
Primary Completion
December 1, 2015
Last Updated
February 20, 2014
Record last verified: 2014-02